Biotech

All Articles

Amgen files very first stage 3 win for $400M eczema drug

.Amgen has actually discussed (PDF) the 1st phase 3 information on its own $400 thousand dermatitis ...

Biogen, UCB file stage 3 lupus win after falling short earlier trial

.Biogen as well as UCB's bank on developing right into period 3 on the back of a broken research hop...

Aptadir hopes brand-new RNA preventions can easily turn around difficult cancers

.Italian biotech Aptadir Rehabs has actually introduced with the commitment that its pipe of preclin...

Wave surfs DMD success to regulatory authorities' doors, sending out stockpile

.Wave Lifestyle Sciences has met its own goal in a Duchenne muscle dystrophy (DMD) study, positionin...

Sanofi picks brand new CSO from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma fold, ...

Achilles drops cell therapy course, braces for cutbacks after missing out on 'commercial stability' targets

.Achilles Therapeutics has actually destroyed its technique. The British biotech is actually quiting...

Aligos proclaims period 2 MASH succeed, lowering liver excess fat around 46%

.Aligos Therapies is heralding a midstage gain in metabolic-dysfunction associated steatohepatitis (...

Basilea credit ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work creating brand new antifungals has gotten a considerable boost coming ...

Capricor markets Europe civil liberties to late-stage DMD therapy for $35M

.Possessing already gathered up the united state rights to Capricor Therapeutics' late-stage Duchenn...

FDA scraps adcomm for Applied's rare condition medication

.After dismissing the choice meeting for Applied Therapeutics' metabolic disorder medication govores...